Stem cells for the treatment of glioblastoma: a 20-year perspective

Glioblastoma, the deadliest form of primary brain tumor, remains a disease without cure. Treatment resistance is in large part attributed to limitations in the delivery and distribution of therapeutic agents. Over the last 20 years, numerous preclinical studies have demonstrated the feasibility and...

Descripción completa

Detalles Bibliográficos
Autores principales: Calinescu, Anda-Alexandra, Kauss, McKenzie C, Sultan, Zain, Al-Holou, Wajd N, O’Shea, Sue K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162173/
https://www.ncbi.nlm.nih.gov/pubmed/34006134
http://dx.doi.org/10.2217/cns-2020-0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162173/
https://www.ncbi.nlm.nih.gov/pubmed/34006134
http://dx.doi.org/10.2217/cns-2020-0026

Ejemplares similares